clinicalomicsprowebdirectory
News
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Marketplace
Multimedia
Clinical OMICs Live
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News
Molecular Dx
Technology for Fast Direct Detection of DNA and RNA has Clinical…
Translational Research
Mitochondrial DNA Triggers Inflammation in Sickle Cell Anemia Patients
Coronavirus
Comprehensive Global COVID-19 Variant Database Launched
Precision Medicine
Illumina Granted Registration in Russia for Clinical NGS Platform, Reagents
Biomarkers
Genetic Change Triggers Brain Cells to Cause ALS
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Molecular Dx
Technology for Fast Direct Detection of DNA and RNA has Clinical…
Translational Research
Mitochondrial DNA Triggers Inflammation in Sickle Cell Anemia Patients
Coronavirus
Comprehensive Global COVID-19 Variant Database Launched
Precision Medicine
Illumina Granted Registration in Russia for Clinical NGS Platform, Reagents
Magazine
Magazine
Clinical OMICs Magazine Volume 8, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 5
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 3
Marketplace
Multimedia
All
Clinical OMICs Live
Webinars
eBooks
Clinical OMICs Live
The GENOME ODYSSEY: Solving Medical Mysteries with Euan Ashley, MD, PhD
On Demand Webinars
Genomic Applications in the Fight against SARS-CoV-2
eBooks
Cell and Gene Therapy Clinical Trials
On Demand Webinars
Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Oncology
Skin Cancer
Skin Cancer
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Skin Cancer
High Levels of IL-33 Can Trigger Skin, Pancreatic Cancer Development
February 22, 2021
Skin Cancer
Graphene Hydrogel Could Help mRNA Vaccine Target Cancer More Effectively
February 17, 2021
Skin Cancer
Melanoma Vaccine from NeoVox Shows Anti-Tumor Response Four Years Later
January 21, 2021
Skin Cancer
Melanoma Metastasis Linked to Higher Midkine Expression
October 23, 2020
Skin Cancer
Skin Cancer Risk Increases if Sun Raises Mutation Count in Melanocyte...
October 8, 2020
Skin Cancer
APOE Variant May Protect Against Melanoma Spread
May 26, 2020
Skin Cancer
University of Arizona Gets $6.9M NCI Grant to Study Skin Cancer...
February 6, 2020
Skin Cancer
New Liquid Biopsy Method IDs Melanoma Patients Likely to Relapse
February 4, 2020
Skin Cancer
Targeting Treg Cell Control Protein Enhances Melanoma Immunotherapy
January 8, 2020
Skin Cancer
Single-Cell Transcriptional Analysis Predicts Melanoma Drug Response
October 9, 2019
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Researchers at The University of Texas MD Anderson Cancer Center have found that a rare resistance mutation first thought to appear in melanoma (pictured) following treatment with a targeted therapy has instead turned out to be hiding in the tumor all along. [Definiens]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1519-324x160.jpeg "Melanoma Vaccine from NeoVox Shows Anti-Tumor Response Four Years Later")
![HLI and Merck KGaA will focus on identifying biomarkers in patients with locally advanced or metastatic NRAS mutated cutaneous melanoma that show a preferential response to Merck’s pimasertib.. [© M&S Fotodesign/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1132-324x160.jpeg "APOE Variant May Protect Against Melanoma Spread")
![ArcherDX said its Archer Immunoverse and VariantPlex NGS assays will be used by Ambry toward offering its biopharma customers large-scale immune repertoire analysis and chimeric antigen T-cell receptor (CAR-T) manufacturing characterization and pharmacodynamics. [royaltystockphoto/Getty Images]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1550-324x160.jpeg "Targeting Treg Cell Control Protein Enhances Melanoma Immunotherapy")
